Cancer Drug Proves to Be Effective Against Multiple Tumors

Cancer Drug Proves to Be Effective Against Multiple Tumors

The drug, pembrolizumab, sold as Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they appear in the body. Just 4 percent of cancer patients have the type of genetic aberration susceptible to pembrolizumab. But that adds up to a lot of patients: as many as 60,000 each year in the United States alone, the study’s investigators estimated.

Continue reading…

More great content like this @ Science & Space Front Page or you can Request Invite

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s